Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review

INTRODUCTION: Acral melanoma (AM) has different biological characteristics from cutaneous melanoma. Although systemic therapeutic strategies for advanced AM resemble those for advanced cutaneous melanoma, the evidence of the clinical use of immune checkpoint inhibitors (ICIs) for AM is still inadequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qingyue, Li, Jiarui, Zhang, Hanlin, Wang, Yuanzhuo, Zhang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744720/
https://www.ncbi.nlm.nih.gov/pubmed/33344255
http://dx.doi.org/10.3389/fonc.2020.602705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744720/
https://www.ncbi.nlm.nih.gov/pubmed/33344255
http://dx.doi.org/10.3389/fonc.2020.602705

Ejemplares similares